Observational studyClinical pharmacology and therapeutics2026
Early and High-Dose Glucocorticoid Use and Survival in Advanced NSCLC Receiving Immune Checkpoint Inhibitors: A Multicenter Target Trial Emulation.
Da Eun Lee et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.